By Aaron Biros| 2019-12-02T17:16:28+00:00 December 2nd, 2019|analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, claim, commerce, compliance, drug, epilepsy, Farm Bill, FDA, Federal, food, generally recognized as safe, government, gras, Hemp, industry, ingredient, interstate, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, medical, medicine, product, Product Development, Quality, recreational, regulation, regulations, Regulatory, schedule, Soapbox, state, test, thc, USA, warning|0 Comments
We won’t lie, this is HUGE.
In a whitepaper published last week the National Cannabis Industry Association urges Congress to deschedule cannabis and oversee it with current regulatory infrastructure.
The post NCIA Releases Guidelines for Federal Cannabis Regulation appeared first on Cannabis Industry Journal.
How Would the U.S. Drug Enforcement Administration’s Potential Reclassification of Cannabis Affect Georgia’s Medical Cannabis Industry?
The post Medical Cannabis in Georgia: Federal Policy Effects on State Industries appeared first on Cannabis Industry Journal.
The UK moves to reschedule cannabis as a Schedule II drug.
The post British Government Agrees To Loosen Rules on Prescribing Medical Cannabis appeared first on Cannabis Industry Journal.